Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
International Journal of Cancer|July 13, 2002
In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatmentStefanie Naundorf, Susanne Preithner, Petra Mayer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE classKlaus Brischwein, Larissa Parr, Stefan Pflanz, et al.Cancer Research|April 19, 2007
Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody constructScott A Hammond, Ralf Lutterbuese, Shannon Roff, et al.Cancer Immunology, Immunotherapy : CII|September 28, 2005
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3Bernd Schlereth, Petra Kleindienst, Iduna Fichtner, et al.Journal of Virology|May 4, 2018
Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody ConstructsJohannes Brozy, Erika Schlaepfer, Christina K S Mueller, et al.Leukemia Research|October 7, 2008
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cellsSandrine d'Argouges, Sandra Wissing, Christian Brandl, et al.Cancer Research|January 4, 2008
Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3Maria Amann, Klaus Brischwein, Petra Lutterbuese, et al.Cancer Research|January 10, 2002
Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic diseasePeter Kufer, Alfred Zippelius, Ralf Lutterbüse, et al.Cancer Immunology, Immunotherapy : CII|July 21, 2005
T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody constructBernd Schlereth, Cornelia Quadt, Torsten Dreier, et al.Cancer Research|April 5, 2005
Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody constructBernd Schlereth, Iduna Fichtner, Grit Lorenczewski, et al.Pageof 6